Announcements

Aflac Incorporated filed a Form 8-K with the U.S. Securities and Exchange Commission on November 4, 2026, reporting its third quarter 2026 financial results and furnishing related investor materials.

Franklin Covey Co. filed a Form 8-K on November 4, 2026, announcing its financial results for the fourth quarter and fiscal year ended August 31, 2026, with an earnings release furnished as an exhibit and a shareholder discussion scheduled for the same day.

Citius Oncology, Inc. filed a Form 8-K on November 4, 2026, announcing that it issued a press release presenting health-related quality of life results from pivotal Study 302 of LYMPHIR (denileukin diftitox-cxdl) at the EORTC-CLTG 2026 Annual Meeting.

Xperi Inc. filed a current report on November 4, 2026, disclosing third-quarter 2026 financial results and announcing a planned transition of its Chief Financial Officer role.

MKS Inc. filed an 8-K on November 4, 2026, disclosing a new $500 million share repurchase program, an amendment to its bylaws reducing the special-meeting threshold, and financial results for the quarter ended September 30, 2026.

XMax Inc. filed a Form 8-K on November 4, 2026, disclosing the final voting results from a special meeting of stockholders held on November 2, 2026, at which shareholders voted on four proposals related to share issuances and meeting adjournment authority.

HP Inc. filed a Form 8-K on November 4, 2026, disclosing the appointment of Emma Walmsley as Chief Executive Officer, effective January 4, 2027, along with her compensation arrangements and a bylaw amendment expanding the Board from 12 to 13 directors.